142 related articles for article (PubMed ID: 16280109)
1. Update: NCCN prostate cancer Clinical Practice Guidelines.
Scardino P
J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S29-33. PubMed ID: 16280109
[No Abstract] [Full Text] [Related]
2. Controversies in prostate cancer screening and treatment.
Gaines KK
Urol Nurs; 2010; 30(3):165-6. PubMed ID: 20648853
[No Abstract] [Full Text] [Related]
3. Prostate cancer: screening and treatment options.
Horger DC; Clarke HS
J S C Med Assoc; 2003 Apr; 99(4):85-7. PubMed ID: 12762154
[No Abstract] [Full Text] [Related]
4. Screening for prostate cancer among men 75 years of age or older.
Barry MJ
N Engl J Med; 2008 Dec; 359(24):2515-6. PubMed ID: 19073973
[No Abstract] [Full Text] [Related]
5. The continuing challenge of hormone-refractory prostate cancer.
Sartor O
Clin Genitourin Cancer; 2006 Mar; 4(4):238-9. PubMed ID: 16729904
[No Abstract] [Full Text] [Related]
6. Docetaxel followed by hormone therapy in men experiencing increasing prostate-specific antigen after primary local treatments for prostate cancer.
Hussain A; Dawson N; Amin P; Engstrom C; Dorsey B; Siegel E; Guo C
J Clin Oncol; 2005 Apr; 23(12):2789-96. PubMed ID: 15837994
[TBL] [Abstract][Full Text] [Related]
7. Single-agent chemotherapy with docetaxel significantly reduces PSA levels in patients with high-grade localized prostate cancers.
Berger AP; Niescher M; Fischer-Colbrie R; Pelzer A; Bartsch G; Horninger W
Urol Int; 2004; 73(2):110-2. PubMed ID: 15331892
[TBL] [Abstract][Full Text] [Related]
8. Clinical practice. Screening for prostate cancer.
Hoffman RM
N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
[No Abstract] [Full Text] [Related]
9. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
D'Amico A
BJU Int; 2007 Jan; 99 Suppl 1():13-6; discussion 17-8. PubMed ID: 17229162
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer in the older man: conflict between tumor biology and medical advancement.
Cummings JM
Clin Geriatr Med; 2010 May; 26(2):241-7. PubMed ID: 20497843
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel in androgen-independent prostate cancer: an update.
Khan MA; Carducci MA; Partin AW
BJU Int; 2004 Dec; 94(9):1209-10. PubMed ID: 15610087
[No Abstract] [Full Text] [Related]
12. Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
Kibel AS; Rosenbaum E; Kattan MW; Picus J; Dreicer R; Klein EA; Chatta GS; Nelson JB; DiPaola RS; Roth BJ; Cookson MS; Wilding G; Jarrard DF; Beer TM; Ryan CW; Petrylak DP; Benson MC; Partin AW; Garrett-Mayer E; Eisenberger MA
J Urol; 2007 May; 177(5):1777-81. PubMed ID: 17437819
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic guidelines in prostate cancer and role for bisphosphonates in bone metastasis].
Miki T; Okihara K
Nihon Rinsho; 2007 Nov; 65 Suppl 9():632-5. PubMed ID: 18161177
[No Abstract] [Full Text] [Related]
14. A practical guide to prostate cancer diagnosis and management.
Simmons MN; Berglund RK; Jones JS
Cleve Clin J Med; 2011 May; 78(5):321-31. PubMed ID: 21536828
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer update: 2005.
Ryan CJ; Small EJ
Curr Opin Oncol; 2006 May; 18(3):284-8. PubMed ID: 16552242
[TBL] [Abstract][Full Text] [Related]
16. Clinical practice. Localized prostate cancer.
Walsh PC; DeWeese TL; Eisenberger MA
N Engl J Med; 2007 Dec; 357(26):2696-705. PubMed ID: 18160689
[No Abstract] [Full Text] [Related]
17. A guideline to clinical utility of prostate specific antigen.
Farhat WA; Habbal AA; Khauli RB
Saudi Med J; 2000 Mar; 21(3):223-7. PubMed ID: 11533789
[TBL] [Abstract][Full Text] [Related]
18. Screening for prostate cancer remains controversial.
Stark JR; Mucci L; Rothman KJ; Adami HO
BMJ; 2009 Sep; 339():b3601. PubMed ID: 19778971
[No Abstract] [Full Text] [Related]
19. New trial data do not end the PSA screening debate.
Vastag B
J Natl Cancer Inst; 2009 Jun; 101(12):844-5. PubMed ID: 19509364
[No Abstract] [Full Text] [Related]
20. Localised prostate cancer: which way forward?
Stuart-Harris R; Berry MP
Med J Aust; 1995 Feb; 162(3):116-7. PubMed ID: 7531812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
